Relay Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$18.70

-0.14 (-0.74%)

As of Sep 21, 2:01 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +248.8% upside

Low Target $47.67

Average Target $65.23

High Target $99.61

Current Price $18.70

Current
$18.70

Target
$65.23

$47.67 $65.23 avg $99.61

Scenario Analysis

Bear Case

$47.67

154.9%

Low target

Base Case

$65.23

+248.8%

Avg target

Bull Case

$99.61

+432.7%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$21.27

-12.1% from high

52-Week Low

$4.05

+361.7% from low

Target vs 52W High

$65.23

+206.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%